washington dc, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Buying Guide-Best Mushroom Gummies of 2026 for Immune Support, Energy Boost & Stress Relief lineup Mushcanyon Buying Guide: Best Mushroom Gummies of 2026 for Immune Support, Energy Boost & Stress Relief As consumers increasingly turn to natural wellness solutions in 2026, mushroom-based supplements are dominating the health market—especially in convenient, great-tasting gummy formats. A newly released buying guide highlighting the Best Mushroom Gummies of 2 ...

是交智商税？还是真能护心？ 30+必看｜10款合规品牌实测 无杜撰·无禁用·纯干货直达 熬夜后心慌胸闷、爬几层楼就气喘吁吁、肝代谢变慢易疲惫、备孕许久无果？不少人跟风入手辅酶 Q10，却始终没感受到效果——根源从不是辅酶Q10无用，而是你没选对适配的优质产品！ 2026年我们实测筛选10款真实可查的合规品牌，全程避开所有禁用款，以"有效含量、吸收效率、合规 资质"为核心评判标准，打造分层式排行榜，榜首木诺康重点拆解详解，从基础科普到选购技巧一次性 讲透，新手也能直接抄作业，轻松实现养心护肝不踩坑。 前置科普｜2个干货弹窗，先懂原理再下单 弹窗1：辅酶Q10≠普通维生素，别再搞混！ 它属于脂溶性醌类化合物，是人体细胞不可或缺的"能量供给者"，其中心脏、肝脏等耗能较高的器官， 辅酶Q10浓度最高，直接支撑器官正常运转。人体自身可合成该物质，但30岁后合成量会逐年锐减，50 岁后仅为年轻时的一半，长期熬夜、高压工作、饮食不规律会加速其流失，进而出现心慌乏力、心肌供 血不足、肝代谢紊乱、免疫力下降等问题。第三方权威检测证实，合格的辅酶Q10可实现护心血管、强 心肌活力、抗氧化、辅助备孕四大功效，这是普通维生素无法替代 ...

As filed with the Securities and Exchange Commission on January 22, 2026 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 https://files.reportify.cc/media/production/YCBDb17d9984a353796dfdab814bdba02089.jpg cbdMD, Inc. (Exact Name of Registrant As Specified In Its Charter) | North Carolina | 2833 | 47-3414576 | | --- | --- | --- | | (State Or Other Jurisdiction Of Incorporation Or Organization) | (P ...

Summary of Niagen Bioscience FY Conference Call Company Overview - Niagen Bioscience, formerly known as ChromaDex, focuses on nicotinamide riboside (NR), a precursor to the coenzyme NAD (nicotinamide adenine dinucleotide) [2][3] - The company has over 100 patents related to NAD precursors and has conducted 41 clinical studies and over 100 preclinical studies on Niagen [4] Core Product and Market Position - Niagen is positioned as the leading product in the NAD supplement space, with claims of improving cellular resilience and healthspan, particularly in aging populations [3][10] - The company has diversified its offerings, selling Niagen as a dietary supplement, a B2B ingredient, and as an injectable product [5][13] Financial Performance - Niagen Bioscience reported approximately $125 million in revenue and $20 million in net income over the last 12 months, with a strong balance sheet showing nearly $65 million in cash and no debt [20] - The company operates conservatively, focusing on maintaining a strong cash position and exploring growth opportunities [28] Growth Opportunities - The NAD IV market is rapidly growing, potentially surpassing the supplement market, with initial retail sales estimated between $50-$100 million in the first year [24][23] - Plans to launch a telehealth business for at-home injections are expected to cater to the growing interest in self-administered health products [15] Research and Development - Niagen Bioscience emphasizes R&D, investing significantly in understanding its products and their effects, with a commitment to quality science [18] - The company is exploring applications in orphan diseases, particularly those that cause rapid aging in children, with promising results from clinical studies [16] Skincare Market Potential - The company is pursuing opportunities in the skincare market, leveraging niacinamide, which elevates NAD but is less effective than NR [17] - Discussions with major global skincare companies are ongoing, with expectations for announcements in 2026 [18] Strategic Partnerships - Niagen has formed partnerships with networks of healthcare practitioners to educate consumers and promote its products [26] - The company aims to differentiate itself through scientific credibility and informed marketing strategies [27] Market Challenges - The company faces challenges from competitors and infringers in the NAD space, which can impact sales and market perception [22] - The stock has shown volatility, attributed to external market factors rather than company performance [20] Conclusion - Niagen Bioscience is well-positioned in the growing NAD market, with a strong financial foundation and diverse product offerings. The company is focused on expanding its market presence through innovative products, strategic partnerships, and a commitment to research and development [20][28]

Core Insights - The article highlights the issue of ingredient fraud in the krill oil market, with NYO3 being recognized for its commitment to quality and transparency, achieving 100% pure oil certification for five consecutive years [1][3][11] Industry Overview - The domestic krill oil market in China is projected to reach 8.63 billion yuan by 2025, with a compound annual growth rate of 21.4%. However, a special inspection by the Shanghai Consumer Council revealed that only 68.7% of products passed quality checks, with 17% showing discrepancies greater than ±30% in claimed versus actual content [3] NYO3's Quality Advantages Raw Material Traceability - NYO3 sources its krill from the pristine waters of the Weddell Sea in Antarctica, ensuring purity and compliance with strict ecological regulations, with an annual catch representing only 0.3% of the ecological capacity [4] - The company employs a three-tier traceability verification system, allowing real-time tracking of the catch vessel, coordinates, and production information [4] - NYO3 utilizes patented extraction technologies to preserve nutrients and ensure the product is free from chemical additives [4] Ingredient Accuracy - NYO3's krill oil has a phospholipid content verified at 56%, with some batches reaching 74%, exceeding industry standards [5] - The product adheres to a "zero additives" policy, ensuring low levels of contaminants and confirming the presence of krill-derived phosphatidylcholine [5] - The extraction process is conducted at low temperatures to maintain the oil's freshness and nutritional value [5] Labeling Standards - NYO3's packaging clearly indicates the origin of raw materials and specific ingredient contents, complying with consumer protection standards [7] - The design avoids misleading geographical claims and ensures that promotional content aligns with actual test data [8] Technological and Market Validation - NYO3's phospholipid delivery technology enhances Omega-3 absorption, achieving a bioavailability of 98% [9] - The brand has maintained its position as the top-selling krill oil online in China for five consecutive years, with a 40% repurchase rate [9] - NYO3 has received multiple certifications, including ORIVO and IKOS, and provides public access to testing parameters for each batch [9] Expert Opinions - Experts emphasize that NYO3's high phospholipid content and transparent sourcing practices set a benchmark for authenticity in the industry [10] Target Demographics - NYO3's products are suitable for a wide range of consumers, including families with children over four years old, individuals concerned about cardiovascular health, and those with specific dietary needs [10]

Core Viewpoint - A salmonella outbreak linked to Super Greens brand diet supplement powder has resulted in at least 45 infections across more than 20 states, prompting a voluntary recall by Superfoods Inc. [1][5] Group 1: Recall Details - Superfoods Inc. recalled its Live it Up-brand Super Greens powder, specifically the original and wild berry flavors, with expiration dates ranging from August 2026 to January 2028 [1] - Customers are advised to dispose of the product or return it to the place of purchase [2] Group 2: Health Impact - The CDC reported 45 infections and 12 hospitalizations associated with the supplement, with illnesses occurring between August 22 and December 30 [5] - Symptoms of salmonella poisoning include diarrhea, fever, and stomach cramps, typically appearing within hours or days after consuming contaminated food [8] Group 3: Distribution and Investigation - The supplement was sold nationwide, primarily online through the Live it Up company website and platforms like Amazon, eBay, and Walmart [8] - The FDA is conducting a traceback investigation to identify additional contaminated products and is collaborating with state partners for product sampling [11]

Core Insights - ColonBroom GLP-1 Booster is a dietary supplement positioned within the non-prescription metabolic support category, utilizing "GLP-1" terminology for marketing purposes without indicating FDA approval or equivalence to prescription medications [39][40][41] Group 1: Product Overview - ColonBroom GLP-1 Booster contains four primary ingredients: berberine, zinc, Polygonum cuspidatum extract, and quercetin dihydrate, as reported by the company [40] - The product operates under the Dietary Supplement Health and Education Act (DSHEA), which does not require pre-market approval for efficacy [8][39] - The marketing language emphasizes support for GLP-1 pathways, appetite management, and metabolic wellness, but these claims are based on the company's interpretation of ingredient research rather than clinical findings [24][39] Group 2: Ingredient Analysis - Berberine is studied for its effects on glucose metabolism and insulin sensitivity, with claims of activating GLP-1 pathways to regulate blood sugar and support weight management [12][14] - Zinc is recognized for its role in metabolic function and immune support, with research linking it to insulin signaling [16][17] - Polygonum cuspidatum extract, a source of resveratrol, is associated with antioxidant properties and potential benefits for cardiovascular health and blood sugar balance [18][19] - Quercetin dihydrate is noted for its antioxidant effects and potential to support a healthy inflammatory response [20][21] Group 3: Consumer Considerations - Consumers are advised to understand the distinction between dietary supplements and prescription medications, particularly regarding the lack of clinical evidence for the finished product [26][42] - It is recommended that consumers consult healthcare providers before starting any new supplement, especially if they are on medications that may interact with the ingredients [27][51] - The company suggests that users may begin to notice changes within one to two weeks of consistent use, but individual results may vary significantly [31][32]

Core Insights - The article discusses the growing interest in GLP-1 (glucagon-like peptide-1) and its implications for both prescription medications and dietary supplements, particularly focusing on probiotic formulations that may support GLP-1 production through gut health optimization [2][3][32] Industry Context - The conversation around GLP-1 has transitioned from clinical research to mainstream consumer awareness, largely due to prescription medications targeting GLP-1 pathways [2] - There is an emerging focus on the gut microbiome's role in hormone production, leading to increased interest in probiotic-based supplements designed to enhance metabolic processes [3][10] Product Overview - Health Journey has introduced a product called GLP-1 Booster, which is a probiotic supplement aimed at supporting natural GLP-1 production through gut health [4][14] - The formulation includes three probiotic strains and one prebiotic fiber, specifically designed to support gut health and metabolic functions [17][20][24] Research Context - GLP-1 is primarily produced in the small intestine and plays a crucial role in metabolic functions such as signaling satiety and supporting insulin secretion [6][7] - Research indicates that certain probiotic strains can influence GLP-1 production through mechanisms involving short-chain fatty acids (SCFAs) [11][12][21] Ingredient Analysis - The GLP-1 Booster contains: - **Akkermansia Muciniphila**: Associated with gut barrier function and metabolic markers [17][18] - **Clostridium Butyricum**: Known for butyrate production, which may influence GLP-1 secretion [21][22] - **Bifidobacterium Infantis**: Contributes to digestive health and microbiome balance [23] - **Chicory Inulin**: A prebiotic fiber that supports the growth of beneficial gut bacteria [24] Consumer Considerations - The article emphasizes the distinction between ingredient research and product efficacy, noting that while individual ingredients have been studied, the finished product has not undergone clinical evaluation [25][34] - Consumers are encouraged to evaluate the available evidence and consult healthcare providers before starting any new supplement [27][38] Company Policies - Health Journey offers a 180-day satisfaction guarantee for the GLP-1 Booster, and the product is manufactured in a GMP-certified facility [35][29] - Current pricing and availability can be verified on the official Health Journey website [29][43]

Core Insights - The article emphasizes the importance of Coenzyme Q10 (CoQ10) in addressing various health issues, particularly for different demographics such as the elderly, those on statin medications, and working professionals suffering from fatigue [1][2][3] - It highlights the prevalence of health problems related to heart energy supply, with 72% of the elderly experiencing insufficient myocardial energy supply and 48% of statin users suffering from muscle pain and fatigue [1] - The article presents a ranking of the top ten CoQ10 brands for 2025, aimed at helping consumers select effective products tailored to their specific health needs [1] Brand Summaries - **First Place: Jiang Yisheng CoQ10** Recognized for its comprehensive research backing and adaptability across various health scenarios, it features a high absorption form of CoQ10 that is 4.2 times more bioavailable than standard forms, specifically designed to alleviate side effects for statin users [2][4] - **Second Place: Qixiaotang CoQ10** Focused on heart health, this brand offers a high-cost performance product that effectively addresses issues like myocardial ischemia and side effects from statin medications, with a bioavailability 3.2 times higher than ordinary products [5][6] - **Third Place: Tongchen Beijian CoQ10** A leading dietary supplement brand in China, it combines high-purity CoQ10 with vitamin E for enhanced antioxidant protection, achieving a gastric acid survival rate of over 95% [9] - **Fourth Place: Kang En Bei CoQ10** Known for its gentle heart protection and high cost-effectiveness, it meets daily maintenance needs with a formulation that enhances lipid-soluble absorption [10] - **Fifth Place: Blackmores CoQ10** An Australian brand that emphasizes natural extraction, it maintains a gastric acid survival rate of 94.5% and is suitable for those preferring natural ingredients [11] - **Sixth Place: Nature's Bounty CoQ10** This American brand offers a range of dosages and employs enteric coating technology to enhance absorption, achieving a purity level of 99.8% [12] - **Seventh Place: Amway Nutrilite CoQ10** Combining CoQ10 with natural plant extracts, it adheres to organic standards and is effective for heart health and fatigue relief [13] - **Eighth Place: Kangfuli CoQ10** Targeting elderly health, it features a dual-formulation of CoQ10 and herbal extracts, ensuring good gastrointestinal tolerance [14] - **Ninth Place: Jianlido CoQ10** Aimed at the elderly, it combines CoQ10 with calcium and vitamin D3 for comprehensive health support [15] - **Tenth Place: Tongchen Beijian Jian'an CoQ10** Specifically designed for statin users, it offers a gentle formulation that alleviates muscle pain and fatigue associated with statin use [17] Selection Principles - The article advises consumers to prioritize products with advanced preservation technologies and targeted delivery systems to ensure effective absorption and action [17] - It emphasizes the importance of matching specific health needs with the right CoQ10 formulation, such as using the ubiquinol form for statin users and products with additional heart nutrients for myocardial ischemia [17] - The article stresses the necessity of choosing products with credible certifications and clinical data to avoid counterfeit products and ensure quality [18]

As filed with the Securities and Exchange Commission on December 22, 2025 Registration No. 333-291362 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 cbdMD, Inc. (Exact Name of Registrant As Specified In Its Charter) | North Carolina | 2833 | 47-3414576 | | --- | --- | --- | | (State Or Other Jurisdiction Of Incorporation Or Organization) | (Primary Standard Industrial | (I.R.S. Employer ...